---
figid: PMC10523227__WJD-14-1349-g007
pmcid: PMC10523227
image_filename: WJD-14-1349-g007.jpg
figure_link: /pmc/articles/PMC10523227/figure/F7/
number: Figure 7
figure_title: ''
caption: 'SCG3 plays a vital role in diabetic retinopathy via glycosylation. A: Structure
  of SCG3; B: Molecular docking simulation with RAGE (green, left) and SCG3 (orange,
  right); C: PNGase F cleavaged Scg3. NG: 5 mmol/l glucose containing ECM-treated
  human retinal microvascular endothelial cells (hRMECs) group; HG: 30 mmol/L glucose
  containing ECM-treated hRMECs group; GG: 0.4 Î¼M genipin + 30 mmol/L glucose containing
  ECM-treated hRMECs.'
article_title: Genipin relieves diabetic retinopathy by down-regulation of advanced
  glycation end products via the mitochondrial metabolism related signaling pathway.
citation: Ke-Xin Sun, et al. World J Diabetes. 2023 Sep 15;14(9):1349-1368.
year: '2023'

doi: 10.4239/wjd.v14.i9.1349
journal_title: World Journal of Diabetes
journal_nlm_ta: World J Diabetes
publisher_name: Baishideng Publishing Group Inc

keywords:
- Genipin
- Human retinal microvascular endothelial cells
- Angiogenesis
- Vascularization
- Secretogranin III
- Diabetic retinopathy

---
